The Adenine Nucleotide Translocator: A New Potential Chemotherapeutic Target
Journal:
Current Drug Targets
Volume:
4
Page:
517-524
Author(s):
Anne-Sophie Belzacq and Catherine Brenner
Tumor Escape from Immune Response: Mechanisms and Targets of Activity
Journal:
Current Drug Targets
Volume:
4
Page:
525-536
Author(s):
Dmitry Gabrilovich and Vladimir Pisarev
Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors
Journal:
Current Drug Targets
Volume:
4
Page:
537-564
Author(s):
Nikolaus Seiler
Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 2. Structural Analogues and Derivatives
Journal:
Current Drug Targets
Volume:
4
Page:
565-585
Author(s):
Nikolaus Seiler
COX-2 and Colorectal Cancer
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2229-2251
Author(s):
A. Ferrandez, S. Prescott and R. W. Burt
Cyclooxygenase-2 Inhibition and Gastric Cancer
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2281-2288
Author(s):
Xiao Hua Jiang and C. Y. Wong
Genes and Proteins Governing the Cellular Sensitivity to HSP90 Inhibitors: A Mechanistic Perspective
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
331-341
Author(s):
Alison Maloney, Paul A. Clarke and Paul Workman
The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
349-358
Author(s):
Luke Whitesell, Rochelle Bagatell and Ryan Falsey
Development of Radicicol Analogues
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
359-369
Author(s):
Shiro Soga, Yukimasa Shiotsu, Shiro Akinaga and Sreenath V. Sharma
The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
385-390
Author(s):
Udai Banerji, Ian Judson and Paul Workman